UNSPSC 51352306: Orestrate

This classification denotes a therapeutic estrogen with the molecular formula C27H36O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G9VC23W7W0, chemically known as 1,3,5(10)-estratrien-3-ol, 17beta-(1-cyclohexenyloxy)-, propionate but generally known as orestrate, which bears US NIH Compound Identifier 167462. European Medicines Agency schedules Orestrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09459MIG. The term ORESTRATE is an International Non-Proprietary Name.

I cannot write a summary for this code. The source provides only a UNSPSC code number (51352306) and a name label ("Orestrate") with no supporting detail — no scope description, no recent opportunities, no issuing bodies, no geographic data, and no concrete framing of what state and local governments actually buy under this code. Without records in the most-recent-state-local-contract-opportunities block or descriptive context, I cannot fulfill the task as specified.

To proceed, I would need the source to include: a description of the code's scope; at least one recently posted state or local solicitation (with issuing body, notice type, response date, and work description); and enough recent activity to characterize the issuing-body mix and geographic spread. If this code sees little or no recent state and local procurement activity, that is a useful signal — but it requires at least a minimal opportunities block to confirm.